Premium
Reply to COVID‐19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors
Author(s) -
Cattaneo Chiara,
Cairoli Roberto,
Rossi Giuseppe
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33431
Subject(s) - medicine , cohort , incidence (geometry) , myeloid leukemia , imatinib , cohort study , covid-19 , disease , pediatrics , infectious disease (medical specialty) , physics , optics